Dalteparin contraindications: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
Created page with "__NOTOC__ {{Dalteparin}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== *Active major bleeding *History of heparin induced thrombocytopenia or heparin induced thrombocyto..."
 
ShiSheng (talk | contribs)
No edit summary
Line 11: Line 11:
**For prolonged [[VTE]] prophylaxis.
**For prolonged [[VTE]] prophylaxis.


*[[Hypersensitivity]] to [[heparin]] or pork products{{Cite web  | last =  | first =  | title = FRAGMIN (DALTEPARIN SODIUM) INJECTION [EISAI INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5cd4a8e-14c0-440b-b453-9f3d3250c951 | publisher =  | date =  | accessdate = 2 February 2014 }}
*[[Hypersensitivity]] to [[heparin]] or pork products<ref>{{Cite web  | last =  | first =  | title = FRAGMIN (DALTEPARIN SODIUM) INJECTION [EISAI INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5cd4a8e-14c0-440b-b453-9f3d3250c951 | publisher =  | date =  | accessdate = 2 February 2014 }}</ref>





Revision as of 15:20, 2 February 2014

Dalteparin
FRAGMIN® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications


References

  1. "FRAGMIN (DALTEPARIN SODIUM) INJECTION [EISAI INC.]". Retrieved 2 February 2014.

Template:WikiDoc Sources